Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVERMUSC: Oral Ivermectin for Trachoma Vector Control
NCT07657143Phase 4Not yet recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Oct 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 4 trial of CHILD-IVITAB in trachoma, sponsored by London School of Hygiene & Tropical Medicine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
CHILD-IVITAB
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT07657143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657143.